The medical device reprocessing market has been significantly growing with the increase in demand for reprocessed medical devices because of their lower cost.
According to the Association of Medical Device Preprocessors, medical device reprocessing has become one of hospitals' most celebrated supply chain cost reduction strategies. Sterilization and disinfection are essential to ensure that medical instruments and machines do not transmit infectious pathogens to patients, according to the Centers for Disease Control (CDC). Reprocessed medical devices offer reliable patient care, advanced healthcare infrastructure, skilled professionals, and cost-efficient medical procedures that benefit low-income patients. In addition, the cost of the reprocessed device can be nearly half that of new devices. The rise in chronic diseases (cancer, heart disease, stroke, and arthritis) and increasing surgical procedures are expected to nudge future market growth.
Within the report, the market is segmented into type, product and services, device type, application, and geography. By type, the market is bifurcated into enzymatic and non-enzymatic detergent. On the basis of product and service, the market is segmented into reprocessing support & services and reprocessed medical devices. On the basis of device type, the market is segmented into critical, semi-critical, and non-critical devices. Based on application, the market is segmented into cardiology, general study, orthopedic, gastroenterology, urology, and others. By end user, the market is segmented into hospitals, clinics, home healthcare, diagnostic centers, manufacturers, ambulatory surgical centers, and others. Geographically, the market is sub-segmented into North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa.
A catheter reprocessing system ensures the safe reprocessing of catheters and various essential medical devices.
Reprocessing the medical device is a process of cleaning, sterilizing, testing, remanufacturing, disinfecting, and wrapping as well as labeling a used, expired, and undamaged medical device to make it patient-ready at a much-reduced cost. It is a unique process or treatment in preparation for the reuse of medical devices. For diagnosis and treatment purposes, reusable medical devices are used and manufactured for reprocessing and reuse. CRS is an automated system that safely reprocesses medical devices with minimal human intervention, ensuring doctor-patient safety. Therefore, it is a far-reaching technology that will empower the growth of the futuristic market.
Rising adoption of reprocessed devices is the major factor accelerating the market growth.
Reprocessing is a detailed procedure for cleaning, disinfecting, and sterilizing medical equipment. Reprocessed devices are vital for the patient's safety, preventing healthcare-associated infections (HAIs). Reprocessing medical equipment has gained a lot of attention, not just across hospitals but also among the manufacturers who seek it as a means of upping their game and deriving substantial competitive advantage. According to a Fraunhofer Institute for Environmental, Safety, and Energy Technology study, reprocessed electrophysiology (EP) catheters reduce the environmental impact by nearly half matched to a new device. Despite the increasing cost of new technology, the safe and effective reuse of medical devices has become a strategy among hospitals to remain profitable. Clinicians, especially in the electrophysiology and catheterization labs, have relied on medical device reprocessors to save thousands of dollars per device. Other applications such as general study, orthopedic, gastroenterology, urology, and others are also encouraging the use of these reprocessed devices.
Recent strategic developments in the medical device reprocessing market
The medical device reprocessing market has undergone several significant developments, and a few of these have been mentioned below:
The medical device reprocessing market is driven by several players by implementing strategic activities such as investments, new launches, mergers & acquisitions, and partnerships. Stryker Corporation, Johnson & Johnson, Vanguard AG, Medtronic PLC, Steris Healthcare, Innovative Health, Northeast Scientific, INC., Cardinal Health (Sustainable Technologies), SureTek Medical, and Konoike Group are among the prominent players operating in the market.
The target audience for the report:
Scope of the report:
In this report, the market has been segmented based on:
Companies profiled
- Stryker Corporation
- Johnson & Johnson
- Vanguard AG
- Medtronic PLC
- Steris Healthcare
- Innovative Health
- Northeast Scientific, INC.
- Cardinal Health (Sustainable Technologies)
- SureTek Medical
- Konoike Group